Literature DB >> 1655071

Serotonin uptake and imipramine binding in the blood platelets of obsessive-compulsive disorder patients.

B Bastani1, R C Arora, H Y Meltzer.   

Abstract

14C-Serotonin (5-HT) uptake and 3H-imipramine binding (IB) were studied in the blood platelets of 20 obsessive-compulsive disorder (OCD) patients, 53 normal controls (5-HT uptake) and 32 normal controls (IB binding). The maximum number of binding sites (Bmax) was significantly decreased in OCD patients compared to normal controls, but there was no difference in the affinity for 3H-imipramine (Kd). The affinity for 5-HT uptake (Km) was also decreased in the OCD patients but the maximum velocity of 5-HT uptake sites (Vmax) was not significantly different in OCD patients and normal volunteers. There were trends for the Slowness Subscale of the Maudsley Obsessional-Compulsive Inventory (MOCI) to be positively correlated with the Km of 5-HT uptake (p = 0.094), whereas the Global Scale, Checking Subscale, and Doubting Conscientiousness Subscale of MOCI were negatively correlated with the Kd of IB (p = 0.066, p = 0.08, and p = 0.062, respectively). The results provide further evidence for the dysfunction of the serotonergic system in OCD.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1655071     DOI: 10.1016/0006-3223(91)90166-j

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  10 in total

1.  OCD is associated with an altered association between sensorimotor gating and cortical and subcortical 5-HT1b receptor binding.

Authors:  Christopher Pittenger; Thomas G Adams; Jean-Dominique Gallezot; Michael J Crowley; Nabeel Nabulsi; Hong Gao; Stephen A Kichuk; Ryan Simpson; Eileen Billingslea; Jonas Hannestad; Michael Bloch; Linda Mayes; Zubin Bhagwagar; Richard E Carson
Journal:  J Affect Disord       Date:  2016-02-09       Impact factor: 4.839

2.  Platelet serotonergic markers as endophenotypes for obsessive-compulsive disorder.

Authors:  Richard Delorme; Catalina Betancur; Jacques Callebert; Nadia Chabane; Jean-Louis Laplanche; Marie-Christine Mouren-Simeoni; Jean-Marie Launay; Marion Leboyer
Journal:  Neuropsychopharmacology       Date:  2005-08       Impact factor: 7.853

3.  Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization.

Authors:  S Ramamoorthy; A L Bauman; K R Moore; H Han; T Yang-Feng; A S Chang; V Ganapathy; R D Blakely
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

Review 4.  Eating disorder and obsessive-compulsive disorder: neurochemical and phenomenological commonalities.

Authors:  J L Jarry; F J Vaccarino
Journal:  J Psychiatry Neurosci       Date:  1996-01       Impact factor: 6.186

5.  Monoamine activity reflected in urine of young patients with obsessive compulsive disorder, psychosis with and without reality distortion and healthy subjects: an explorative analysis.

Authors:  R D Oades; B Röpcke; C Eggers
Journal:  J Neural Transm Gen Sect       Date:  1994

Review 6.  Treatment consideration and manifest complexity in comorbid neuropsychiatric disorders.

Authors:  Tomas Palomo; Richard M Kostrzewa; Richard J Beninger; Trevor Archer
Journal:  Neurotox Res       Date:  2007-07       Impact factor: 3.911

Review 7.  Serotonin Transporter Ala276 Mouse: Novel Model to Assess the Neurochemical and Behavioral Impact of Thr276 Phosphorylation In Vivo.

Authors:  Carina Meinke; Meagan A Quinlan; Krista C Paffenroth; Fiona E Harrison; Cristina Fenollar-Ferrer; Rania M Katamish; Isabel Stillman; Sammanda Ramamoorthy; Randy D Blakely
Journal:  Neurochem Res       Date:  2021-04-08       Impact factor: 3.996

Review 8.  Pharmacotherapeutic Strategies and New Targets in OCD.

Authors:  Christopher Pittenger
Journal:  Curr Top Behav Neurosci       Date:  2021

9.  Serotonin transporter gene polymorphism and psychiatric disorders: is there a link?

Authors:  Mushtaq A Margoob; Dhuha Mushtaq
Journal:  Indian J Psychiatry       Date:  2011-10       Impact factor: 1.759

10.  Updated overview of the putative role of the serotoninergic system in obsessive-compulsive disorder.

Authors:  Bruno Aouizerate; Dominique Guehl; Emmanuel Cuny; Alain Rougier; Pierre Burbaud; Jean Tignol; Bernard Bioulac
Journal:  Neuropsychiatr Dis Treat       Date:  2005-09       Impact factor: 2.570

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.